Hologic

Hologic
Hologic
HOLX
NASDAQ
81.24 USD
11.69%

About

Hologic, Inc. is a medical technology company focused on improving women's health and well-being through early detection and treatment. It is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical and Skeletal Health.

Diagnostics segment offers a range of diagnostic products, which are used to aid in the screening and diagnosis of human diseases. Breast Health segment offers a portfolio of solutions for breast cancer care in the areas of radiology, breast surgery, pathology and treatment. It also offers wireless breast surgery localization and lymphatic tracing solutions.

GYN Surgical segment products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Fluent fluid management system and Acessa ProVu laparoscopic radiofrequency ablation system. Skeletal Health segment products include Horizon DXA Systems and Fluoroscan Insight FD..

Financials Amount (in millions)

Income statement
Balance sheet
Cash flow

Ratios

Price and Volume
Volume
Ten Day Average Volume 1.3M
Three Month Average Volume 32.4M
High Low
Fifty-Two Week High 84.67 USD
Fifty-Two Week Low 64.02 USD
Fifty-Two Week High Date 09 Aug 2024
Fifty-Two Week Low Date 30 Oct 2023
Price and Volume
Current Price 81.24 USD
Beta 1
Relative Price Change
Four Week Relative Price Change -8.06%
Thirteen Week Relative Price Change 2.88%
Twenty-Six Week Relative Price Change 0.32%
Fifty-Two Week Relative Price Change -13.26%
Year-to-Date Relative Price Change -3.98%
Price Change
One Day Price Change 0.59%
Thirteen Week Price Change 10.11%
Twenty-Six Week Price Change 10.31%
Five Day Price Change 1.23%
Fifty-Two Week Price Change 8.70%
Year-to-Date Price Change 13.70%
Month-to-Date Price Change -0.45%
Per Share Data
Book Value
Book Value Per Share (Last Fiscal Year) 20.75595 USD
Book Value Per Share (Most Recent Quarter) 21.33494 USD
Tangible Book Value Per Share (Last Fiscal Year) 3.50421 USD
Tangible Book Value Per Share (Most Recent Quarter) 4.18951 USD
EBITD
EBITD Per Share (Trailing Twelve Months) 5.12842 USD
Revenue
Revenue Per Share (Last Fiscal Year) 16.19734 USD
Revenue Per Share (Trailing Twelve Months) 16.59103 USD
Dividend
Dividend Per Share (Last Fiscal Year) -99999.99 USD
Dividend Per Share (Trailing Twelve Months) 0 USD
Dividend Per Share (5 Year) -99999.99 USD
Earnings Per Share
Excluding Extraordinary Items (Last Fiscal Year) 1.83257 USD
Excluding Extraordinary Items (Trailing Twelve Months) 2.93047 USD
Normalized (Last Fiscal Year) 2.61184 USD
Basic Excluding Extraordinary Items (Last Fiscal Year) 1.84786 USD
Basic Excluding Extraordinary Items (Trailing Twelve Months) 2.9519 USD
Including Extraordinary Items (Last Fiscal Year) 1.83257 USD
Including Extraordinary Items (Trailing Twelve Months) 2.93047 USD
Cash
Cash Per Share (Last Fiscal Year) 11.26354 USD
Cash Per Share (Most Recent Quarter) 10.51082 USD
Cash Flow Per Share (Last Fiscal Year) 3.13225 USD
Cash Flow Per Share (Trailing Twelve Months) 4.20809 USD
Free Cash Flow Per Share (Trailing Twelve Months) 4.22098 USD
Margins
Cash Flow Revenue
Cash Flow Revenue (5 Year) 29
Cash Flow Revenue (Trailing Twelve Months) 25
Pretax Margin
Pretax Margin (Trailing Twelve Months) 19.79%
Pretax Margin (Last Fiscal Year) 16.78%
Pretax Margin (5 Year) 24.78%
Gross Margin
Gross Margin (Last Fiscal Year) 55.85%
Gross Margin (Trailing Twelve Months) 55.41%
Gross Margin (5 Year) 60.29%
Operating Margin
Operating Margin (Last Fiscal Year) 16.58%
Operating Margin (Trailing Twelve Months) 19.69%
Operating Margin (5 Year) 26.52%
Net Profit Margin
Net Profit Margin (Last Fiscal Year) 11.31%
Net Profit Margin (Trailing Twelve Months) 17.59%
Net Profit Margin (5 Year) 20.95%
Growth
Book Value
Book Value Per Share (5 Year) 18.21%
Tangible Book Value (5 Year) -99,999.99%
Free Operating Cash Flow
Free Operating Cash Flow (5 Year) 7.51%
Revenue
Revenue Change MRQ vs 1 Year Ago 2.74%
Revenue Growth (3 Year) 4.61%
Revenue Change (Trailing Twelve Months) -1.26%
Revenue Per Share Growth 6.73%
Revenue Growth (5 Year) 2.19%
Capital Spending Debt
Capital Spending (5 Year) 7.30%
Total Debt (5 Year) -3.14%
Dividends
Dividend Growth (3 Year) -99,999.99%
Earnings Per Share
EPS Change MRQ vs 1 Year Ago 601.45%
EPS Change (Trailing Twelve Months) 51.65%
EPS Growth (3 Year) -99,999.99%
EPS Growth (5 Year) -24.24%
EBITDA
EBITDA (5 Year) 5.05%
EBITDA (5 Year Interim) 4.63%
Net Profit Margin
Net Profit Margin Growth (5 Year) -99,999.99%
Valuation
Total Price to Book
Price to Tangible Book (Last Fiscal Year) 22
Price to Tangible Book (Most Recent Quarter) 19
Price to Free Cash Flow
Price to Free Cash Per Share (Last Fiscal Year) 21
Price to Free Cash Per Share (Trailing Twelve Months) 19
Net Debt
Net Debt (Most Recent Quarter) 120.1M
Net Debt (Last Fiscal Year) 114.1M
Price to Sales
Price to Sales (Last Fiscal Year) 5
Price to Sales (Trailing Twelve Months) 5
Price to Earnings
PE Excluding Extraordinary Items (Last Fiscal Year) 28
PE Normalized (Last Fiscal Year) 31
PE Basic Excluding Extraordinary Items (Trailing Twelve Months) 25
PE Excluding Extraordinary Items High (Trailing Twelve Months) 171
PE Excluding Extraordinary Items Low (Trailing Twelve Months) 8
PE Including Extraordinary Items (Trailing Twelve Months) 28
Dividends
Dividend Yield (5 Year) -99,999.99%
Dividend Yield -99,999.99%
Current Dividend Yield 0.00%
Price to Book
Price to Book (Last Fiscal Year) 4
Price to Book (Most Recent Quarter) 4
Financial Strength
Debt to Equity
Long Term Debt to Equity (Last Fiscal Year) 51
Long Term Debt to Equity (Most Recent Quarter) 51
Payout Ratio
Payout Ratio (Last Fiscal Year) 0.00%
Payout Ratio (Trailing Twelve Months) 0.00%
Quick Ratio
Quick Ratio (Last Fiscal Year) 3
Quick Ratio (Most Recent Quarter) 3
Enterprise Value
Current Enterprise Value to Free Cash Flow (Last Fiscal Year) 30
Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) 22
Current Ratio
Current Ratio (Last Fiscal Year) 3
Current Ratio (Most Recent Quarter) 4
Free Cash Flow
Free Cash Flow (Last Fiscal Year) 901.0M
Free Cash Flow (Trailing Twelve Months) 1.0B
Net Interest Coverage
Net Interest Coverage (Last Fiscal Year) -100,000
Net Interest Coverage (Trailing Twelve Months) 710
Total Debt to Equity
Total Debt to Equity (Last Fiscal Year) 57
Total Debt to Equity (Most Recent Quarter) 52
Management Effectiveness
Return on Assets
Return on Assets (Last Fiscal Year) 5.01%
Return on Assets (Trailing Twelve Months) 7.70%
Return on Assets (5 Year) 11.40%
Return on Equity
Return on Equity (Last Fiscal Year) 9.22%
Return on Equity (Trailing Twelve Months) 13.85%
Return on Equity (5 Year) 25.77%
Return on Investment
Return on Investment (Last Fiscal Year) 5.68%
Return on Investment (Trailing Twelve Months) 8.64%
Return on Investment (5 Year) 13.38%

Cookie Settings

We use cookies to deliver and improve our services, analyze site usage, and if you agree, to customize or personalize your experience and market our services to you. You can read our Cookie Policy here.